Status:
WITHDRAWN
Topical 5% Tranexamic Acid as a Treatment for Postinflammatory Hyperpigmentation Due to Acne Vulgaris
Lead Sponsor:
Wayne State University
Conditions:
Postinflammatory Hyperpigmentation
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
PHASE3
Brief Summary
The goal of this study is to determine if topical tranexamic acid is capable of decreasing the pigment of the dark spots left from acne bumps. The first line medication used for this often is not tole...
Eligibility Criteria
Inclusion
- Age 18 to 65
- Patients with bilateral involvement of facial postinflammatory hyperpigmentation due to acne vulgaris.
Exclusion
- Pregnant patients or patients planning to become pregnant during the time of the study.
- Patients with a history of use of hydroquinone, kojic acid, tretinoin, adapalene, tazarotene or azaleic acid in the previous 3 months.
Key Trial Info
Start Date :
November 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 9 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03361345
Start Date
November 1 2018
End Date
January 9 2022
Last Update
May 16 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
WSUPG Dermatology
Dearborn, Michigan, United States, 48124